Polar Capital Global Healthcare Trust to remove fixed life structure

Polar Capital Global Healthcare Trust (PCGH) announced a significant corporate reorganization, proposing to replace its fixed life structure with periodic 100% tender offers to shareholders, commencing by March 31, 2031. This strategic shift, supported by key shareholders, aims to provide regular liquidity while maintaining the trust's long-term global healthcare investment strategy. Concurrently, PCGH will eliminate performance fees, adopting a new tiered management fee structure (0.70% on the first £500M and 0.65% thereafter), which could enhance fee predictability and investor alignment.

Analysis

Polar Capital Global Healthcare Trust PLC (PCGH) has announced a significant corporate reorganization aimed at enhancing shareholder value and long-term viability. The central proposal involves replacing its fixed-life structure with a framework that includes a 100 percent tender offer by March 31, 2031, and every five years thereafter. This move, which has received positive initial feedback from key shareholders, provides a clear liquidity mechanism for investors wishing to exit, a feature that can help manage the trust's discount to net asset value (NAV). Concurrently, the trust is overhauling its fee structure by eliminating the performance fee and implementing a tiered management fee of 0.70% on the first £500 million of assets and 0.65% on assets above that threshold. This change simplifies costs and increases predictability for investors. Importantly, the core investment mandate remains unchanged, with a continued focus on long-term capital growth from a diversified portfolio of global healthcare stocks and a gearing limit of 15% of NAV. These structural and fee adjustments are shareholder-friendly and reflect a strategic pivot towards a more sustainable and attractive model for both existing and prospective investors.

Key Decisions for Investors

• Existing investors should view the proposed changes, particularly the periodic tender offers and fee simplification, as positive for long-term value and may consider holding their position, as these measures could help narrow the trust's discount to NAV over time.
• Prospective investors seeking exposure to the global healthcare sector should evaluate PCGH more closely, as the new, more predictable fee structure and defined exit opportunities make it a structurally more attractive investment vehicle.
• Investors should monitor the forthcoming shareholder circular for the final proposal details and the subsequent shareholder vote, as the implementation of these value-enhancing measures is contingent on formal approval.